Cas:9002-86-2 Poly(vinyl chloride) manufacturer & supplier

We serve Chemical Name:Poly(vinyl chloride) CAS:9002-86-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Poly(vinyl chloride)

Chemical Name:Poly(vinyl chloride)
CAS.NO:9002-86-2
Synonyms:MFCD00084459;Poly(vinyl chloride);Ethene, chloro-​, homopolymer;EINECS 208-750-2;PVC Resin K 65;PVC
Molecular Formula:C2H5Cl
Molecular Weight:64.51410
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.4 g/mL at 25 °C(lit.)
Index of Refraction:
PSA:
Exact Mass:64.00800
LogP:1.24510

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD00084459 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,PVC physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00084459 Use and application,Ethene, chloro-​, homopolymer technical grade,usp/ep/jp grade.


Related News: As far as chemical raw materials are concerned, China occupies a large share in the field of bulk raw materials and has become one of the world’s largest suppliers of chemical raw materials. Poly(vinyl chloride) manufacturer Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they��ve been to mainland China in last 14 days. Poly(vinyl chloride) supplier As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. Poly(vinyl chloride) vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. Poly(vinyl chloride) factory Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.